Jubilant Pharmova’s June quarter profit dropped 45% year-on-year to ₹56.4 crore, even as revenue from operations climbed 17.3% to ₹2,229.4 crore. EBITDA fell 14.4% to ₹248 crore, while EBITDA margin narrowed to 11.1% from 15.2% a year earlier, weighing on the company’s bottom line.
